Skip to main content
. 2016 Mar 21;48:765–771. doi: 10.1007/s11255-016-1255-6

Fig. 1.

Fig. 1

Receiver operator curve analysis showing the threshold daily intake for K1 resulting in increased plasma concentration of PIVKA-II (>0.66 ng/mL)